TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion November 3, 1978
TCL Archive Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays June 1, 1979
TCL Archive Review Of Cancer Center supports Grants Needs Refocus On Science, Advisors Say October 18, 1996